Finance
Results: 433-444 of 48070

Lundbeck announces headline results from Phase IV THRIVE trial evaluating VYEPTI® (eptinezumab) following inadequate response to prior CGRP-targeting preventive therapy

Orifarm Unveils 2031 Strategy to Accelerate Growth Across Europe, With Significant Expansion in Generics

Skanska to build and renovate academic buildings in Fredericksburg, USA, for USD 163M, about SEK 1.5 billion






